IDiyas

For the Inventor, By the Inventor

Somerville, MA, United States of America

Bettina Strack-Logue

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Lexington, MA (US) (2018 - 2021)
  • Somerville, MA (US) (2016 - 2023)

Company Filing History:

goldMedal8 out of 86 
 
Shire Human Genetic Therapies, Inc.
 patents
silverMedal2 out of 153 
 
Translate Bio, Inc.
 patents
bronzeMedal1 out of 1,177 
 
Takeda Pharmaceutical Company Limited
 patents

Years Active: 2016-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 11660328 - GLP-2 analogs and peptibodies for administration before, during or after surgery (2023-05-30),
2. 11065307 - Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety (2021-07-20),
3. 10995354 - Modification of RNA-related enzymes for enhanced production (2021-05-04),
4. 10722559 - Mannose-6-phosphate bearing peptides fused to lysosomal enzymes (2020-07-28),
5. 10603364 - Lysosomal targeting and uses thereof (2020-03-31),
6. 10144942 - Modification of RNA-related enzymes for enhanced production (2018-12-04),
7. 9932377 - Mitochondrial targeting and therapeutic use thereof (2018-04-03),
8. 9814764 - Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase (2017-11-14),
9. 9597376 - Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis (2017-03-21),
10. 9453847 - Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereof (2016-09-27),
11. 9260495 - Mitochondrial targeting and therapeutic use thereof (2016-02-16),

Title: Bettina Strack-Logue: Pioneering Innovations in Medical Therapies

Introduction:

Bettina Strack-Logue, a visionary inventor based in Somerville, MA (US), is a trailblazer in the field of medical therapies. With a passion for innovation and a relentless pursuit of excellence, she has inspired the next generation of innovators to think boldly and push the limits of what is possible.

Latest Patents:

Bettina Strack-Logue holds 11 patents, including groundbreaking inventions such as GLP-2 analogs and peptibodies for administration before, during, or after surgery. These innovations, such as teduglutide and fusion proteins of GLP-2 with immunoglobulin, have the potential to revolutionize post-surgical care, particularly in cases of short bowel syndrome.

Career Highlights:

Throughout her illustrious career, Bettina has made significant contributions to companies like Shire Human Genetic Therapies, Inc. and Translate Bio, Inc. Her innovative spirit and dedication to advancing medical therapies have garnered recognition from peers and industry leaders alike.

Collaborations:

Bettina has collaborated with esteemed professionals in the field, including coworkers Michael F Concino and Angela Norton. Together, they have worked tirelessly to develop novel solutions for complex medical challenges, leaving a lasting impact on the industry.

Conclusion:

In conclusion, Bettina Strack-Logue's unwavering commitment to innovation and her groundbreaking inventions have cemented her legacy as a visionary inventor in the field of medical therapies. Her contributions continue to inspire and shape the future of healthcare, paving the way for transformative advancements in patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…